|
KIF3C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.371100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25399999999043E-05 |
| Normal-vs-Stage2 |
3.732600E-01 |
| Normal-vs-Stage3 |
9.111800E-02 |
| Normal-vs-Stage4 |
2.431800E-02 |
| Stage1-vs-Stage2 |
8.561300E-03 |
| Stage1-vs-Stage3 |
1.147620E-02 |
| Stage1-vs-Stage4 |
6.210400E-01 |
| Stage2-vs-Stage3 |
5.861600E-01 |
| Stage2-vs-Stage4 |
1.508760E-01 |
| Stage3-vs-Stage4 |
2.635800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.098800E-03 |
| Normal-vs-AfricanAmerican |
1.496630E-03 |
| Normal-vs-Asian |
1.604630E-01 |
| Caucasian-vs-AfricanAmerican |
5.041700E-02 |
| Caucasian-vs-Asian |
2.580000E-01 |
| AfricanAmerican-vs-Asian |
4.747600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.909720E-02 |
| Normal-vs-Female |
2.7928000000399E-06 |
| Male-vs-Female |
1.302120E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.916900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.792800E-04 |
| Normal-vs-Age(61-80Yrs) |
8.143700E-03 |
| Normal-vs-Age(81-100Yrs) |
9.336800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.344200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.260000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.841580E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.142000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.907900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.290200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.464300E-03 |
| Normal-vs-Grade 2 |
2.841300E-04 |
| Normal-vs-Grade 3 |
4.515800E-02 |
| Normal-vs-Grade 4 |
7.115300E-03 |
| Grade 1-vs-Grade 2 |
3.355600E-03 |
| Grade 1-vs-Grade 3 |
4.998900E-04 |
| Grade 1-vs-Grade 4 |
1.325580E-02 |
| Grade 2-vs-Grade 3 |
7.865900E-02 |
| Grade 2-vs-Grade 4 |
9.023400E-01 |
| Grade 3-vs-Grade 4 |
1.759160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.163800E-03 |
| Normal-vs-ccB subtype |
1.235410E-03 |
| ccA subtype-vs-ccB subtype |
2.800400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.880400E-03 |
| Normal-vs-N1 |
4.054000E-02 |
| N0-vs-N1 |
1.676170E-01 |
|
|
